The First Affiliated Hospital Of Xiamen University
Clinical trials sponsored by The First Affiliated Hospital Of Xiamen University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can gentle zaps to acupoints ease Post-Surgery gut woes? Results expected Nov 2026 (estimated)
- Could a simple scan replace biopsies for key cancer marker? Results expected Nov 2026 (estimated)
- Could stem cell eye drops soothe dry eyes? Results expected Nov 2026 (estimated)
- New scan could spot hidden cancers Results expected Dec 2026 (estimated)
- Can a new PET tracer spot thyroid cancer recurrence more clearly? Results expected Dec 2026 (estimated)
-
Poop pills plus chemo: new hope for stubborn colon cancer?
Disease control Not yet recruitingThis early-phase trial tests whether transplanting gut bacteria from young donors (via capsules or a tube) can help immunotherapy work better in people with a type of advanced colorectal cancer that usually doesn't respond to immunotherapy. Ten patients who have already tried sta…
Early phase 1 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Experimental combo aims to boost immune attack on tough cancers
Disease control Not yet recruitingThis early-stage trial tests a combination of two drugs—peginterferon alfa-2b and an anti-PD-1 antibody—in about 60 people with advanced or metastatic solid tumors who have no standard treatment options left. The main goal is to find a safe dose and check for side effects. Resear…
Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug cocktail aims to shrink breast tumors before surgery
Disease control Not yet recruitingThis early-phase study is testing whether combining two targeted drugs (pyrotinib and dalpiciclib) with standard hormone therapy can shrink tumors in people with HR+HER2 low breast cancer before they have surgery. The study plans to enroll 33 patients with locally advanced diseas…
Phase 1/2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Popular diabetes drug semaglutide under scrutiny for bone effects
Disease control Not yet recruitingThis study looks at whether semaglutide (a diabetes drug that lowers blood sugar and helps with weight loss) affects bone density and fracture risk in people with type 2 diabetes. About 150 adults aged 50–75 will get either semaglutide plus metformin or metformin alone for 12 mon…
Phase 4 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 26, 2026 17:38 UTC